Overview

• End-O Check was officially launched by Apollo Cancer Centres and Apollo Proton Cancer Centre in Navi Mumbai as a structured early detection program for ovarian and endometrial cancers.
• The program targets high-risk postmenopausal women aged 45 and above through risk-based assessments, symptom evaluation and transvaginal ultrasonography diagnostics.
• Experts at the launch highlighted that five-year survival rates can exceed 90% when ovarian and endometrial cancers are detected at a localized stage.
• A panel of Apollo specialists emphasized the need for awareness campaigns, equitable access to preventive tools and offered fertility preservation options via ovum freezing.
• End-O Check underscores a strategic shift from reactive treatment to precision-led preventive oncology as India’s cancer burden approaches 1.57 million cases.